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Paediatric heart surgery is associated with increased inflammation and the production of reactive oxygen species. Use of the
extracorporeal cardiopulmonary bypass during correction of congenital heart defects generates reactive oxygen species by various
mechanisms: haemolysis, neutrophil activation, ischaemia reperfusion injury, reoxygenation injury, or depletion of the endogenous
antioxidants. The immature myocardium is more vulnerable to reactive oxygen species because of developmental differences
compared to the adult heart but also because of associated congenital heart diseases that can deplete its antioxidant reserve.
Oxidative stress can be manipulated by various interventions: exogenous antioxidants, use of steroids, cardioplegia, blood prime
strategies, or miniaturisation of the cardiopulmonary bypass circuit. However, it is unclear if modulation of the redox pathways
can alter clinical outcomes. Further studies powered to look at clinical outcomes are needed to define the role of oxidative stress in
paediatric patients.
1. Introduction
The stress response to surgery compromises a series of
humoral, metabolic, or cellular reactions [1]. Cardiac surgery
with use of cardiopulmonary bypass (CPB) is a major acti-
vator of the systemic inflammatory response (SIRS) [2, 3]. In
some instances, SIRS, rather than being a homeostatic mech-
anism, can be overactivated and result in multiorgan failure
and increased mortality after surgery [2]. Inflammation,
resulting in neutrophil activation, plays a central role in the
production of reactive oxygen species (ROS) [4, 5]. However,
other pathways such as haemolysis, ischaemic reperfusion
injury, or reoxygenation of the hypoxic myocardium can also
generate free radicals. When there is an imbalance between
the production of ROS and the antioxidant capacity of the
body, oxidative stress occurs resulting in cellular injury. Very
few studies looked at the impact of oxidative stress on the
immature heart, and little is known about the differences
between the developing heart and the mature heart during
oxidative stress. Although the immature heart has a greater
antioxidant capacity than the adult heart, certain congenital
conditions that we address surgically make it more suscep-
tible to free radical oxidation [6]. Theoretically, modulation
of these oxidative pathways could be of great importance
to clinical practice. However, it is unclear how oxidative
stress correlates with clinical outcomes after paediatric heart
surgery. The current review focuses on the mechanisms of
free radical production during paediatric heart surgery, the
particularities that make the immature heart more prone to
oxidative damage but also on the possible interventions that
could mitigate ROS production.
2. Free Radicals, Reactive Oxygen
Species, Mitochondrial Oxidative Stress,
and Antioxidant Enzymes
Free radicals are chemical species with a single unpaired
electron making them highly unstable and reactive. The role
of oxygen derived free radicals was studied in the context of
cell injury secondary to ischaemic reperfusion injury, inflam-
mation, phagocytosis, chemical or radiation injury, oxygen
toxicity, and cell aging [7]. Reactive oxygen species refers to
free radicals and other oxidants without an unpaired electron
such as the highly reactive hydrogen peroxide (H
2
O
2
).
The main types of reactive oxygen species are the super-
oxide anion (O
2
∙−), hydrogen peroxide (H
2
O
2
), the hydroxyl
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radicals (∙OH), peroxynitrite (ONOO−), and the hypochlo-
rite radical (OCl−) [2, 5–8].
Reactive oxygen species are produced under physiolog-
ical conditions during the mitochondrial respiration process
by the reduction-oxidation reactions (redox). A toxic reactant
escaping this reaction is the O
2
∙− radical that can convert,
spontaneously or under the action of the superoxide dis-
mutase, to H
2
O
2
. The so-called Fenton reaction can further
generate from H
2
O
2
the highly reactive hydroxyl radical
(∙OH).
Mitochondria are the energy factory of the body but also a
major source of reactive oxygen.Themitochondrial transport
chain can leak electrons to molecular oxygen resulting in
superoxide radical production. When the mitochondrial
antioxidant capacity is overwhelmed,mitochondrial oxidative
stress can cause mitochondrial DNA damage, impaired mito-
chondrial respiration, and lipid or protein peroxidation. Such
processes are responsible for DNA mutations, cellular aging,
and death. An important mechanism is the peroxidation
of cardiolipin, a mitochondrial lipid protein that results in
cytochrome C release and subsequent caspase activation and
apoptosis [9–13].
A recently discovered antioxidant system is the mito-
chondrial thioredoxin and peroxiredoxin family of proteins
[14]. This scavenger complex is an important regulator of the
redox state but also a regulator of cell apoptosis via the apop-
tosis stress kinase 1 (ASK 1).Themitochondrial thioredoxin-2
can preserve cardiac function by suppressing ROS within the
mitochondria according to a study [15].
Within the activated phagocyte, a similar chain of reac-
tions occurs. Of great importance is the production of the
superoxide anion (O
2
∙−) by the reaction of oxygen with
nicotinamide adenine dinucleotide phosphate (NADPH).
This reaction is catalysed by the NADPH-oxidase, a mem-
brane specific enzyme. Another key enzyme is the myeloper-
oxidase that catalyses the reaction of the halide ions (Cl−)with
H
2
O
2
, thus generating the OCl−, the “bleach” of the phago-
cyte [5].
Cell injury occurs by three main mechanisms: lipid
peroxidation, protein oxidative damage, and DNA damage
(Figure 1) [7, 8]. Nonspecific markers of lipid peroxidation
such as the thiobarbituric acid-reactive substances (TBARS)
had been used in previous studies to measure outcomes after
paediatric heart surgery [16]. Antioxidant enzymes such as
the superoxide dismutase, the glutathione synthetic enzymes,
and the catalases can protect cells against the oxidative
stress. As we will see later, both endogenous and exogenous
antioxidants such as vitamins C, E, and A or beta-carotene
can also enhance the antioxidant capacity [7].
Apart from their important role in microbial killing, ROS
are also involved in cell signaling [7, 17, 18].TheNF-𝜅B family
of transcription factors are involved in inflammation, immu-
nity, cellular growth, or apoptosis. There is a complex cross
talk between ROS and NF-𝜅B: transcription of the NF-𝜅B
gene that regulates the production of ROS in the cell but also
NF-𝜅B activity can be influenced by ROS. Furthermore, NF-
𝜅B can mediate the expression of antioxidant proteins such
as superoxide dismutases, ferritin heavy chain, thioredoxins,
and glutathione peroxidase [18].
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Figure 1: The various reactive oxygen species (ROS) injure cells
by three main mechanisms: lipid peroxidation, protein oxidative
damage, andDNAdamage. Cellular injury is limited by the action of
themain antioxidant enzymes (scavengers).There is a complex cross
talk between ROS and NF-𝜅B transcription factors that regulate the
production of antioxidants.
3. Paediatric Extracorporeal
Circuits and Oxidative Stress
Use of the extracorporeal circuits induces oxidative stress in
various ways, ultimately resulting in organ system dysfunc-
tion (Figure 1).
3.1. Extracorporeal Circuits, Inflammation, Oxidative Stress,
and Markers of Oxidation. Several factors cause a more
profound systemic inflammatory response in neonates and
infants compared to older children or adults: (1) the surface
and the volume of the CPB circuit relative to the blood vol-
ume and patient size, (2) more frequent use of hypothermic
circulatory arrest, and (3) more pronounced haemodilution
[6]. It is well known that CPB induces systemic inflammation
by mechanisms such as contact activation with the non-
self-circuit surfaces, translocation of intestinal endotoxins,
general surgical trauma, blood loss, or hypothermia [2,
19]. This activates the complement system, the production
of cytokines, neutrophil adhesion and aggregation, nicoti-
namide adenine dinucleotide phosphate (NADPH) oxidase,
and xanthine oxidase systems, ultimately resulting in ROS
production [2, 4, 5, 8, 20]. Certainly, the recruitment and
activation of neutrophils play a pivotal role in the production
of ROS. Activation of neutrophils leads to an increase of the
plasma neutrophil elastase and the increase of myeloperoxi-
dase enzyme linked to oxidative stress [21]. Measurement of
the myeloperoxidase can be used as a marker of cardiovascu-
lar disease [22].
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Figure 2:The various mechanisms of production of ROS with use of extracorporeal circuit.The immature myocardium is vulnerable to ROS
injury because of age specific differences compared to the adult heart but also because of coexistent congenital heart disease. The end-result
is contractile dysfunction.
Calza et al. [23] evaluated the glutathione redox cycle
in the context of paediatric CPB. They found increased free
radical production before and during CPB by measuring an
increase of the total and oxidised glutathione (reduction of
the glutathione/glutathione oxidase ratio).
Gil-Go´mez et al. [24] found a direct correlation between
the time of extracorporeal circulation, the duration of post-
operative mechanical ventilation, and the amplitude of the
oxidative stress response. The authors measured glutathione
levels but also the lipid peroxidation product, malondialde-
hyde. Other products of lipid peroxidation such as isoflurane
or 8-isoprostanewere found to be increased during paediatric
CPB [23, 25, 26].
Extracorporeal membrane oxygenation (ECMO) is com-
monly used in paediatric heart surgery. Similar to the CPB
circuit, contact activation initiates an inflammatory cascade
and oxidative stress. Extracorporeal membrane oxygenation
is a major activator of SIRS because the whole blood of the
patient is in contact for days or weeks with the ECMO circuit
[8]. Hirthler et al. [27] in the nonsurvivors after paediatric
ECMO found elevated levels of the lipid peroxidation mark-
ers: thiobarbiturate acid-reactive substances (TBARS) and
malondialdehyde.
3.2. Ischaemic Reperfusion Injury and Oxidative Stress in the
Immature Myocardium. Ischaemic reperfusion injury (IRI)
following cardioplegic arrest results in increased ROS pro-
duction. The main sources of ROS during IRI are (1) uncou-
pling of the mitochondrial electron transport, (2) circulating
polymorphonuclear leukocytes generating superoxide anions
from NADPH (reaction catalysed by the NAPDH oxidase),
and (3) coronary endothelial cells that generate the super-
oxide anion from hypoxanthine, reaction catalysed by the
xanthine oxidase enzyme [28]. Ischaemic reperfusion injury
results in cardiac dysfunction, a major cause‘of mortality
and morbidity in paediatric cardiac surgery [16, 29, 30].
Reactive oxygen species can induce contractile dysfunction
(low cardiac output syndrome) by peroxidation of the sar-
colemma and of the contractile proteins. This results in
calcium overload and calciumdesensitization (Figure 2) [28].
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Previous studies suggested that the immature heart is
more tolerant to ischaemia than the adult heart. Possible
mechanisms implicated are as follows: (1) the sarcolemma
of the cell is more resistant to calcium, (2) the immature
myocardium relies on fatty acid for energy production and
hence less potential for anaerobic glycolysis, and (3) the
larger amount of amino acids provides more substrates of
anaerobicmetabolism [6, 16, 23]. Despite such developmental
differences, the myocardium in cyanotic heart disease and
heart failure might be more susceptible to ischaemia and
subsequently oxidative stress [16, 23, 30]. The pressure over-
load of the myocardium in left to right shunts or outflow
obstructions, or the reduced oxygen availability in cyanotic
heart disease, further reduces the ATP stores and antioxidant
enzymes, thus making the myocardium more susceptible to
oxidative injury [23, 31, 32]. Cabigas et al. [33] compared
oxidative stress in the newborn and adult heart in a model of
ischaemic reperfusion injury. They found age and chamber
specific differences related to oxidative stress. Interestingly,
the newborn right ventricle myocytes showed significantly
higher production of H
2
O
2
compared to the adult heart,
the superoxide dismutase activity increased only in the right
ventricle heart, and the catalase activity and levels were all
reduced in the newborn heart.
Reactive oxygen species play a fundamental role in reper-
fusion injury and their effect had been extensively studied
in this context [8]. During IRI, oxidants are produced by
various mechanisms such as increased production of xan-
thine oxidase production by the endothelial cells, decreased
function of the glutathione peroxidase enzyme, or leakage
of electrons from the mitochondria (resulting in superox-
ide anions) [8]. The activated neutrophil with subsequent
fabrication of ROS seems to play a role in more prolonged
periods of ischaemia that are associated with tissue necrosis
[8, 34]. Oliveira et al. [35] in an immunohistological study
of infants that underwent repair of cardiac malformations
found lipid peroxidation to be the mechanism responsible
for myocardial injury. The authors tested immunoreactivity
to 4-hydroxynonenal, a lipid peroxidation product, and
nitrotyrosine, a tyrosine nitration product, mediated by the
peroxynitrite radical.
Manso et al. [16] questioned the role of oxidative stress
in myocardial dysfunction or low cardiac output after heart
surgery. The authors found no correlation between TBARS
and carbonyl moieties and the development of low cardiac
output syndrome in a retrospective study of 55 children. Cer-
tainly, further studies powered to look at clinical outcomes
and oxidative stress in paediatric surgery are required.
3.3. Hypoxemic/Reoxygenation Induced Oxidative Stress in
Cyanotic Heart Disease. Buckberg et al. [29, 36] demon-
strated in animal studies that the reintroduction of oxygen
in the initial stages of CPB or mechanical ventilation can
induce per se myocardial injury in the hypoxaemic myo-
cardium. In cyanotic heart disease, the reduction of the
antioxidant reserve increases the vulnerability of the myocar-
dium.The authors demonstrated that reoxygenation reduced
the myocardial reserve capacity (measured by incubating
myocardial tissue in the oxidant t-butyl hydroperoxide) and
increased the products of lipid peroxidation (conjugated
dienes) measured in coronary sinus and the myocardial
tissue.
Caputo et al. randomized cyanotic patients to receive
either normoxic or hyperoxic cardiopulmonary bypass. The
normoxic arm of patients had less oxidative stress (signifi-
cantly lower 8-isoprostane levels) compared to the hyperoxic
group [26]. Later studies by the same group demonstrated less
oxidative stress with controlled reoxygenation in the single
ventricle compared to double ventricle patients [25].
3.4. Extracorporeal Circuits and the Antioxidant Reserve.
Oxidative stress during CPB is an imbalance between the
production of free radicals and the antioxidant capacity of
the body. As discussed earlier, congenital cardiac conditions
are associated with a decrease of the myocardial antioxidant
capacity. However, CPB can also deplete the plasma antiox-
idant capacity. Cavarocchi et al. demonstrated depletion of
vitamin E after bypass [37, 38]. Pyles et al. [39] investigated
in vitro the plasma ability to prevent lipid peroxidation (mal-
ondialdehyde production) in beef brain homogenate media.
They found the plasma antioxidant capacity significantly
reduced after congenital heart surgery with CPB.
3.5. Haemolysis, Blood Transfusion, and Iron Overload Pro-
moteOxidative Stress . Thecontact with the nonphysiological
surfaces of the bypass circuit and the associated mechanical
shear stress associated with CPB leads not only to inflam-
mation but also to haemolysis [40–42]. The resulting free
haemoglobin can react with H
2
O
2
and generate redox active
low molecular mass iron that can lead to lipid peroxida-
tion and the highly reactive hydroxyl radical (∙OH) [42].
Iron overload in paediatric cardiac surgery can result also
from blood cardioplegia, ischaemia reperfusion injury, blood
transfusion, or the use blood prime [40].
Blood transfusion is a common practice in heart surgery
that promotes oxidative stress by both the decreased antiox-
idant properties of stored blood and increased erythrocyte
fragility resulting in haemolysis and ROS generation [4]. Low
molecular mass iron is present in small amounts within cells
for synthesis of fetoproteins or DNA. Under normal condi-
tions, iron is regulated by ligands such as transferrin that
inhibits transfer of electron from iron to molecular oxygen
[42, 43]. When the iron binding capacity of transferrin is
exceeded, free iron can be detected in the plasma. Notably,
Mumby et al. [40] found a higher plasma iron overload in
neonates undergoing CPB compared to older children. A
possible explanation was the lower transferrin concentration
within this group. Another study of patients undergoing
tetralogy of Fallot repair found acute right ventricular failure
due to restrictive physiology to be associated with severe
iron loading of transferrin and increased oxidative stress
markers compared to the nonrestrictive physiology cohort
[44]. Two paediatric studies [42, 45] found associations
between haemolysis and renal dysfunction that was believed
to be mediated by lipid peroxidation.
Christen et al. [19] found the peak of oxidative stress
markers (malondialdehyde and carbonyls) to occur before
the rise of the inflammatory cytokines (interleukin-6 and
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Figure 3: Interventions to reduce oxidative stress in paediatric heart
surgery.
interleukin-8) in paediatric patients undergoing heart sur-
gery with CPB. This further suggests that mechanisms such
as haemolysis could be responsible for the propagation of
oxidative stress.
4. Modulation of Oxidative Stress in
Paediatric Heart Surgery
Figure 3 summarises the various interventions on oxidative
stress after heart surgery.
4.1. Antioxidants. Children, particularly newborns, are more
prone to oxidative stress because of several factors: (1)
surfactant deficiency that exposes them to higher oxygen
concentration, (2) less efficient antioxidant reserves, (3) being
more prone to sepsis and inflammation, and (4) higher levels
of free iron than older children [14]. Buckberg [29] studies
defined the concept of antioxidant reserve capacity on the
immature heart by incubating cardiac muscle with oxidants
and measuring the products of lipid peroxidation. The dose
response was similar to the Starling volume load curves and
suggested the relation between antioxidant depletion and
oxidative stress. Cardiopulmonary bypass had been shown
to reduce plasma antioxidant capacity [19, 39]. Christen et al.
[19] found a decrease in ascorbate (vitamin C) levels coupled
with an increase in dehydroascorbate (oxidised vitamin C)
andmalondialdehyde levels in paediatric patients undergoing
heart surgery. Therefore, increasing the antioxidant reserve
capacity by administration of exogenous agents seems bene-
ficial.
As seen previously, iron can play an important role in free
radical formation; hence, chelators such deferoxamine could
prove to be advantageous. Morita et al. [32] found adminis-
tration deferoxamine to increase the heart antioxidant reserve
in piglets undergoing CPB.
Data from critically ill patients or adult patients under-
going heart surgery suggests that supplementation of antiox-
idant micronutrients such as vitamin C, selenium, zinc,
or vitamin E could increase the antioxidant defence [2, 4,
8, 46]. Amino acids are well known to have antioxidants
properties [4]. For example, L-arginine reduced markers of
oxidative stress in adult cardiac surgery when added to the
cardioplegia solution [47]. The nonessential amino acid glu-
tamine is another important endogenous antioxidant that
could be supplemented [8]. N-acetylcysteine, antioxidant,
and mucolytic agent used in respiratory medicine reduced
the incidence of postoperative atrial fibrillation in a ran-
domized controlled trial [48]; however, a later meta-analysis
of randomized trials showed no benefit in reducing renal
dysfunction, haemodialysis, or death [49]. To our knowledge,
there are no studies investigating the effect of the above agents
on oxidative stress in children undergoing heart surgery.
England et al. [50] found mannitol to reduce lipid per-
oxidation in patients undergoing adult heart surgery; how-
ever, its use was not evaluated in paediatric heart surgery.
Allopurinol, an inhibitor of the purine metabolism, acts on
the xanthine oxidase pathway generation [50] of superoxide.
Some studies suggested reduced oxidative stress in paediatric
heart surgery [50, 51] while others suggested it might not be
beneficial [52]. One study on neonateswith respiratory failure
requiring ECMO demonstrated reduced purine degradation
and uric acid production, hence with possible reduction in
free radicals during reperfusion and reoxygenation injury
[53].
The induction andmaintenance anaesthetic agent, propo-
fol, exerts antioxidant effects on the adult heart [4]. Xia et al.
[54] in a study on 20 children undergoing CPB demonstrated
reduced expression of NF-𝜅B in the propofol group. As seen
earlier, oxidative stress is associated with the activation of
the NF-𝜅B transcriptional factor. The same research group
compared the antioxidant effects of the sedative midazolam
to those of propofol in children undergoing congenital heart
surgery. The propofol group had significantly less oxidative
stress (lower superoxide dismutase and malondialdehyde
levels) compared to the midazolam group [55].
Salvia miltiorrhiza, a herb extract with potent antioxidant
effects, prevented the increase of lipid peroxidation products
(malondialdehyde) in children undergoing CPB according to
a study [56].
Melatonin is an endogenous indolamine, known to be a
potent anti-inflammatory molecule but also a direct antioxi-
dant [46, 57, 58]. In neonatal sepsis [46] but also after neona-
tal gastrointestinal surgery [57], melatonin reduced markers
of oxidative stress. In several studies, using human cardiomy-
ocytes cultures or isolated perfused rat heart, melatonin
effectively reduced oxidative damage [59]. Further clinical
studies in paediatric heart surgery are required to validate the
above findings.
Aprotinin is used in congenital heart surgery as haemo-
static agent but is also known to exert anti-inflammatory
effects. Several paediatric studies suggested reduced oxidative
stress with its use [60, 61].
As seen earlier, the mitochondrion is the main contrib-
utor to ROS production. Recently, agents that target the
mitochondrial redox systems are being developed. MitoQ
is a ubiquinone derivate conjugated to triphenylphospho-
nium that accumulates within the mitochondria because of
an electrochemical gradient [4]. Ubiquinone is known for
inhibiting the production of lipid peroxyl in the cell [13].
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MitoQ reduced IRI in murine models of heart infarction [62]
or heart transplant [12]. As opposed to the MitoQ lipophilic
antioxidant that accumulates within the mitochondria in a
potential-dependent manner, a novel class of small peptides
(Szeto-Schiller) that selectively permeate the mitochondrial
membrane had also been developed [10]. Szeto-Schiller pep-
tides reduced IRI in several in vivo and ex vivo experimental
models [10].
4.2. Glucocorticoids and CPB-Induced Oxidative Stress. Glu-
cocorticoids are widely used in paediatric heart surgery to
blunt the systemic inflammatory response to surgery but
also to treat presumed postoperative adrenal insufficiency.
Checchia et al. [63] in an international survey on steroid use
in paediatric heart surgery found that 35 out of 36 centres
(97%) give steroids but there is very wide variability in dose,
timing, regimens, and type of steroid given. A laterUK survey
by Allen et al. [64] demonstrated that 80% of the centres
give steroids. According to a more recent US large database
retrospective study in 2010, steroids were used in 54% of
the paediatric cases. Despite wide use of glucocorticoids and
proven anti-inflammatory effects in heart surgery with CPB
[65–67], the majority of the studies have failed to show a
survival benefit with steroids use [68–73]. Furthermore, large
retrospective studies reported higher infection rates with
steroids use [70, 71]. A recent large retrospective randomized
trial in adult heart surgery found no significant effect of
methylprednisolone on mortality or morbidity after cardiac
surgery [74]. Similarly, a large, multicentre randomized trial
in the paediatric population is warranted before firm recom-
mendations can be made.
Steroids exert an anti-inflammatory effect by activating
the cytoplasmic glucocorticoid receptor (GR) in the target
tissues. The glucocorticoid-glucocorticoid receptor complex
dissociates from its chaperone (the heat shock protein family
hsp90) and translocates to the nucleus where it associates
with the glucocorticoid response elements of various genes to
induce expression of anti-inflammatory genes [75–77]. Ster-
oids can also inhibit the activation of the NF-𝜅B redox sensi-
tive transcription factors that play a central role in oxidative
stress [76, 77].
Very few studies looked at the effect of steroids on inflam-
mation and oxidative stress and cardiac function [76, 78].
Valen et al. [76] found increased activity of the tissue catalase
and glutathione peroxidase in the isolated rat heart pretreated
with methylprednisolone. Withington et al. [78] randomized
54 infants undergoing heart surgery with CPB to three
different regimens of methylprednisolone (preoperative, at
induction, and in the prime fluid). The prime administration
group had less oxidative stress (higher glutathione to oxidised
glutathione ratio).
Despite some studies [76] suggesting an increase of the
antioxidant capacity with steroid treatment in the myocar-
dium or other tissues [79], effects of glucocorticoids on
oxidative stress remain controversial. For example, studies on
hippocampal cell cultures demonstrated that steroids could
promote oxidative stress induced death [80, 81]. Recently,
several studies demonstrated a proinflammatory action of
steroids depending on time and context of administration
thus creating more controversy [82, 83].
4.3. Miniaturisation of the Extracorporeal Circuit. Mini-CPB
bypass was developed in adult heart surgery in an attempt to
reduce contact activation, air fluid interface, and cell damage
by cardiotomy suction and haemodilution. Minimising such
disadvantages of conventional CPB tempers the proinflam-
matory response to surgery but also the associated oxidative
stress [84]. Adult studies demonstrated less oxidative stress
with the use of mini-CPB [85]. The need to maintain an ade-
quate haematocrit but also to overcome the patient’s size and
circuit discrepancy led to development of paediatric minicar-
diopulmonary. As seen earlier, the possibility of the bloodless
prime eliminates the deleterious effects of blood transfusion.
This is achieved in several ways: creation of biocompatible-
coated circuits and oxygenators, vacuum assisted drainage
systems, reducing the length of the circuit, or eliminating
certain circuit components [84].Miyaji et al. [86] successfully
used mini-CPB in neonates weighing more than 4 kg. A
more recent study by the same group demonstrated reduced
inflammatory response with the use of mini-CPB in patients
undergoing the Fontan procedure [87]. To our knowledge,
there are no studies investigating differences between oxida-
tive stress with conventional CPB andmini-CPB in paediatric
heart surgery.
4.4. Cardioplegia, Pump Prime, and Oxidative Stress. Reac-
tive oxygen species production can be controlled by enrich-
ment of cardioplegia solution with antioxidants according
to both experimental [88–90] and adult studies [91–95].
Early experimental studies demonstrated the superiority of
blood cardioplegia over crystalloid cardioplegia in reducing
oxidative damage [96].This could be explained by the natural
antioxidants blood constituents: haemoglobin, superoxide
dismutase, catalase, and glutathione [90]. Despite these
potential benefits of the blood cardioplegia, other studies
suggested increased oxidative stress by either iron overload
[40] or increase of hypoxanthine levels [97]. Finally, adult
studies demonstrated less oxidative stress with intermittent
antegrade warm blood cardioplegia compared to cold blood
cardioplegia [98]. Calza et al. [23] found controlled antegrade
low oxygen warm reperfusion to reduce oxidative stress and
promote myocardial recovery.
Pump prime solutions used in neonatal heart surgery can
also influence the antioxidant plasma capacity.This can prove
to be significant because of the relation of the blood circulat-
ing volume and the volume of the extracorporeal circuit [99].
Previous animal studies demonstrated that supplementation
of the prime solution with catalase reduces myocardial
oxidative damage in the piglet heart [100]. Molicki et al. [99]
investigated the antioxidant capacity of two different prime
solutions for cardiopulmonary bypass in neonates: albumin
or fresh frozen plasma based. Both prime solutions had
no total radical antioxidant parameter value (ability of the
investigated prime solution to inhibit peroxidation of a target
lipid).However, the ferric-reducing ability (the capacity of the
prime to reduce ferric ion to the ferrous form) was reduced
in the prime solution compared to the undiluted, standard
albumin and fresh frozen plasma. In their study, they also
demonstrated that ultrafiltration led to loss of antioxidants
and was ineffective in clearing lipid peroxidation products.
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In addition, adding mannitol to the prime had no antioxi-
dant effect.The above study highlights not only the dilutional
effect that results during prime preparation but also the
depletion of antioxidants during ultrafiltration.
5. Conclusion
Cardiac surgery with the use of CPB is associated with
altered redox states in children. Reactive oxygen species
cause injury not only by both direct oxidation and perox-
idation of cell membranes but also by cellular signalling.
Contact with the paediatric bypass circuit surfaces activates
the inflammatory cascade in which the neutrophil plays
a central role in manufacturing of ROS. However, early
inflammation-independent mechanisms such as haemolysis
can also contribute to oxidative stress.The generation of ROS
during ischaemic reperfusion injury can result in contractile
dysfunction but nonreperfusion injury by reoxygenation of
the chronically hypoxic heart can also occur. The lack of an
antioxidant reserve or the coexistence of congenital heart
defects associated with hypoxia or pressure load increases
the vulnerability of the immature heart to oxidative dam-
age. A multitude of interventions aimed at reducing ROS
production or at increasing the antioxidant reserve were
reviewed: exogenous antioxidants, steroids, miniaturisation
of the CPB circuit, prime fluid, or cardioplegia strategies.
The effect of such strategies on clinical outcomes, however,
remains controversial. Further clinical studies looking at the
effect of oxidative stress modulation on clinical outcomes
after paediatric heart surgery are needed.
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